Jail-to-Community study tests monthly shots to fight opioid relapse
NCT ID NCT04408313
First seen Jan 31, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This study compares two long-acting injectable medications—extended-release naltrexone and extended-release buprenorphine—for people with opioid use disorder who are leaving jail. About 240 participants from Maryland jails will receive one of the two medications monthly for six months after release. The goal is to see which medication helps people stay in treatment and avoid opioid use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Friends Research Institute
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.